Cargando…

Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation

BACKGROUND: Gastric cancer (GC) is an extremely heterogeneous malignancy with a complex tumor microenvironment (TME) that contributes to unsatisfactory prognosis. METHODS: The overall activity score for assessing the immune activity of GC patients was developed based on cancer immune cycle activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xuan, Zhou, Fengrui, Cheng, Boran, Tong, Gangling, Chen, Minhua, He, Lirui, Li, Zhu, Yu, Shaokang, Wang, Shubin, Lin, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2023
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655707/ https://www.ncbi.nlm.nih.gov/pubmed/38025711 http://dx.doi.org/10.7717/peerj.16317

Ejemplares similares

Efficacy of Olanzapine-Triple Antiemetic Regimen in Patients with Gastrointestinal Tumor and High Risk of Chemotherapy-Induced Nausea and Vomiting Receiving Moderately Emetogenic Chemotherapy: A Retrospective Study
por: Wu, Xuan, et al.
Publicado: (2020)

Enumeration And Characterization Of Circulating Tumor Cells And Its Application In Advanced Gastric Cancer
por: Cheng, Boran, et al.
Publicado: (2019)

Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer
por: Chen, Jiajia, et al.
Publicado: (2020)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer
por: Li, Ai, et al.
Publicado: (2023)

MACC1 regulates PDL1 expression and tumor immunity through the c‐Met/AKT/mTOR pathway in gastric cancer cells
por: Tong, Gangling, et al.
Publicado: (2019)

Development and validation of a personalized classifier to predict the prognosis and response to immunotherapy in glioma based on glycolysis and the tumor microenvironment
por: Fan, Pengfei, et al.
Publicado: (2023)

Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer
por: Qi, Wenqian, et al.
Publicado: (2021)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
por: Chen, Jing, et al.
Publicado: (2021)

Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer
por: Wang, Yali, et al.
Publicado: (2021)

A novel machine learning derived RNA-binding protein gene–based score system predicts prognosis of hepatocellular carcinoma patients
por: Zhang, Qiangnu, et al.
Publicado: (2021)

A risk score model with five long non-coding RNAs for predicting prognosis in gastric cancer: an integrated analysis combining TCGA and GEO datasets
por: Wu, Yiguo, et al.
Publicado: (2021)

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC
por: Wang, Zemin, et al.
Publicado: (2022)

ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021)

Prefoldin subunits (PFDN1–6) serve as poor prognostic markers in gastric cancer
por: Yesseyeva, Galiya, et al.
Publicado: (2020)

Analysis of core genes for colorectal cancer prognosis based on immune and stromal scores
por: Zhu, Yi, et al.
Publicado: (2021)

Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy
por: Li, Kuangxun, et al.
Publicado: (2021)

Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors
por: Su, Yongchao, et al.
Publicado: (2022)

A gene expression-based risk model reveals prognosis of gastric cancer
por: Deng, Xiaorong, et al.
Publicado: (2018)

Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis
por: Ma, Zhenchao, et al.
Publicado: (2021)

Novel pyroptosis-associated genes signature for predicting the prognosis of sarcoma and validation
por: Wen, Hao, et al.
Publicado: (2022)

Construction and validation of a fatty acid metabolism-related gene signature for predicting prognosis and therapeutic response in patients with prostate cancer
por: Zhao, Hongjun, et al.
Publicado: (2023)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathway
por: Yu, Ruoxi, et al.
Publicado: (2019)

Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients
por: Wang, Jukun, et al.
Publicado: (2021)

CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
por: Li, Xin, et al.
Publicado: (2020)

Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer
por: Hu, Qingjiang, et al.
Publicado: (2021)

A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Developing a risk scoring system based on immune-related lncRNAs for patients with gastric cancer
por: Wang, Yuzhi, et al.
Publicado: (2021)

The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
por: Peng, Bi, et al.
Publicado: (2021)

Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study
por: Tong, Gangling, et al.
Publicado: (2020)

Utilizing network pharmacology and experimental validation to investigate the underlying mechanism of phellodendrine on inflammation
por: Hu, Lili, et al.
Publicado: (2022)

High mutations in fatty acid metabolism contribute to a better prognosis of small‐cell lung cancer patients treated with chemotherapy
por: Lyu, Qiong, et al.
Publicado: (2021)

The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer
por: Wang, Mengya, et al.
Publicado: (2021)

Long non-coding RNA polymorphisms on 8q24 are associated with the prognosis of gastric cancer in a Chinese population
por: Zhang, Yangyu, et al.
Publicado: (2020)

Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis
por: Wei, Chao, et al.
Publicado: (2019)

EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
por: Sun, Si, et al.
Publicado: (2020)

Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rt90c8f3tbr0nb1cfaro84l3fm